Aurangabad, India

Purushottam Dattatraya Kulkarni

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignee: Slayback Pharma LLC. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Purushottam Dattatraya Kulkarni. Retrieved from https://idiyas.com/inventor/purushottam-dattatraya-kulkarni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Purushottam Dattatraya Kulkarni

Introduction

Purushottam Dattatraya Kulkarni is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid compositions for oral administration of tofacitinib. His work has implications for the treatment of auto-immune disorders, showcasing his commitment to advancing medical science.

Latest Patents

Kulkarni holds three patents, with his latest inventions focusing on pharmaceutical compositions of tofacitinib. These compositions are designed for oral administration and are stable under varying storage conditions for extended periods. The stable liquid pharmaceutical composition includes tofacitinib at a concentration of about 1 mg/mL or more, a pharmaceutically acceptable liquid vehicle, at least one anti-oxidant, and optionally other pharmaceutically acceptable excipients. His inventions also describe methods for treating auto-immune disorders using these stable compositions.

Career Highlights

Kulkarni is currently associated with Slayback Pharma LLC, where he continues to innovate in the pharmaceutical sector. His expertise in formulating stable liquid compositions has positioned him as a valuable asset in his field. His contributions are paving the way for more effective treatments for patients suffering from auto-immune disorders.

Collaborations

Some of his notable coworkers include Sushant Omprakash Dube and Purushottam Sakhahari Pattewar. Their collaborative efforts contribute to the innovative environment at Slayback Pharma LLC.

Conclusion

Purushottam Dattatraya Kulkarni's work in developing stable pharmaceutical compositions demonstrates his dedication to improving healthcare solutions. His patents reflect a significant advancement in the treatment of auto-immune disorders, highlighting his role as an influential inventor in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…